New knowledge of genetic pathogenesis of hemochromatosis and Wilson's disease

Advances in Internal Medicine

Volumn 44, Issue , 1999, Pages 91-116

  Bacon, Bruce R ^a   Schilsky, Michael L ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; CATION TRANSPORT PROTEIN; CERULOPLASMIN; COPPER; DNA; WILSON DISEASE PROTEIN;

CHEMISTRY; COST BENEFIT ANALYSIS; ECONOMICS; GENETICS; HEMOCHROMATOSIS; HUMAN; LIVER; MASS SCREENING; METHODOLOGY; MUTATION; PATHOPHYSIOLOGY; REVIEW; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; CARRIER PROTEINS; CATION TRANSPORT PROTEINS; CERULOPLASMIN; COPPER; COST-BENEFIT ANALYSIS; DNA; HEMOCHROMATOSIS; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER; MASS SCREENING; MUTATION;

EID: 0032608789     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Bacon BR, Tavill AS: Hemochromatosis and the iron overload syndromes, in Zakim D, Boyer TD (eds): Hepatology: A Textbook of Liver Disease. Philadelphia, WB Saunders, 1996, pp 1439-1472.
2. Cox DW, Roberts EA: Wilson disease, in Feldman M, Scharschmidt BF, Sleisenger MH (eds): Sleisenger and Fordtran's Gastroenterology and Liver Disease. Philadelphia, WB Saunders, 1998, pp 1104-1112.
3. Knisley AS: Neonatal hemochromatosis. Adv Pediatr 39:303-403, 1992.
4. Gordeuk VR, Mukiibi J, Haastedt SJ, et al: Iron overload in Africainteraction between a gene and dietary iron content. N Engl J Med 326:95-100, 1992.
5. Bacon BR: Causes of iron overload. N Engl J Med 326:126-127, 1992.
6. Simon M, Bourel M, Fauchet R, et al: Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 17:332-334, 1976.
7. Feder NJ, Gnirke A, Thomas W, et al: A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-409, 1996.
8. Bodner JG, Parkam P, Albert ED, et al: Putting a hold on "HLA-H." Nat Genet 15:234-235, 1997.
9. Beutler E, Gelbart T, West C, et al: Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22:187-194, 1996.
10. Jouanolle AM, Gandon G, Jezequel P, et al: Haemochromatosis and HLA-H. Nat Genet 14:251-252, 1996.
11. Jazwinska EC, Cullen LM, Busfield F, et al: Haemochromatosis and HLA-H. Nat Genet 14:249-251, 1996.
12. Carella M, D'Ambrosio L, Totaro A, et al: Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 60:828-832, 1997.
13. Adams PC, Chakrabarti S: Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria. Gastroenterology, 114:319-323, 1998.
14. Bacon BR, Tsuchihashi Z, Thomas W, et al: Genetic analysis in hereditary hemochromatosis. Hepatology 24:294A, 1996.
15. Shaheen NJ, Bacon BR, Grimm IS: Clinical characteristics of patients diagnosed with hereditary hemochromatosis who lack the Cys282Tyr mutation. Gastroenterology 112:1381A, 1997.
16. De Sousa M, Reimao R, Lacerda R, et al: Iron overload in 2-microglobulin-deficient mice. Immunol Lett 39:105-111, 1994.
17. Rothenberg BE, Voland JR: 2 knockout mice develop iron overload: A putative role for class 1 genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sei USA 93:1529-1534, 1996.
18. Santos M, Schilham MW, Rademahers LHPM, et al: Defective iron homeostasis in 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. / Exp Med 184:1975-1985, 1996.
19. McLaren GD, Nathanson MH, Jacobs A, et al: Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. / Lab Clin Med 117:390-401, 1991.
20. Zhou XY, Tomatsu S, Fleming RE, et al: Targeted disruption of HFE gene produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sei USA 95:2492-2497, 1998.
21. Feder JN, Tsuchihashi Z, Irrinki A, et al: The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression. ) Biol Chem 272:14025-14028, 1997.
22. Waheed A, Parkkila S, Zhou XY, et al: Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with 2microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sei USA 94:1238412389, 1997.
23. Parkkila S, Waheed A, Britton RS, et al: Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sei USA 94:2534-2539, 1997.
24. Anderson GJ: Control of iron absorption. / Gastroenterol Hepatol 11:1030-1032, 1996.
25. Parkkila S, Waheed A, Britton RS, et al: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sei USA 94:13198-13202, 1997.
26. Bacon BR, Brown KE: Iron metabolism and disorders of iron overload, in Kaplowitz N (ed): Liver and Biliary Diseases, ed 2. Baltimore, Williams & Wilkins 1996, pp 349-362.
27. Bacon BR, Sadiq S: Hereditary hemochromatosis: Diagnosis in the 1990's. Am J Gastroenterol 92:784-789, 1997.
28. Adams PC, Kertesz AE, Valberg LS: Clinical presentation of hemochromatosis: A changing scene. Am J Med 90:445-449, 1991.
29. Edwards CQ, Griffen LM, Goldgar D, et al: Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. NEnglJ Med 318:1355-1362, 1988.
30. Chapman RW, Morgan MY, Laulicht M, et al: Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sei 27:909-916, 1982.
31. Bacon BR, Faravesh MJ, Janney CG, et al: Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 107:1103-1109, 1994.
32. Di Bisceglie AM, Axiotis ÇA, Hoofnagle JH, et al: Measurement of iron status in patients with chronic hepatitis. Gastroenterology 102:21082113, 1992.
33. Bacon BR, Schratz CL, Britton RS, et al: Presence of the hemochromatosis genotype in patients with liver disease. Gastroenterology 112:1218A, 1997.
34. Phatek PD, Guzman G, Woll JE, et al: Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 154:769-776, 1994.
35. Adams PC, Valberg L: Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping. Gastroenterology 112:1207A, 1997.
36. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6:24-29, 1986.
37. Summers KM, Halliday JW, Powell LW: Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology 12:20-25, 1990.
38. Sallie RW, Reed WD, Shilkin KB: Confirmation of the hepatic iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis. Gut 32:207-210, 1991.
39. Bonkovsky HL, Slaker DP, Bills EB, et al: Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage diseases. Gastroenterology 99:1079-1091, 1990.
40. Deugnier YM, Turlin B, Powell LW, et al: Differentiation between hétérozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: A study of 192 cases. Hepatology 17:30-34, 1993.
41. Wilson SAK: Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver. Brain 34:295-307, 1912.
42. Bearn AG, Kunkel HG: Genetic and biochemical aspects of Wilson's disease. Am J Med 15:442-446, 1953.
43. Scheinberg IH, Sternlieb I: Wilson's Disease. Philadelphia, WB Saunders, 1984.
44. Frommer DJ: Defective biliary excretion of copper in Wilson's disease. Gut 15:125-129, 1974.
45. O'Reilly S, Weber PM, Oswald M, et al: Abnormalities of the physiology of copper. Arch Neural 25:28-32, 1971.
46. Sternlieb I, van den Hamer CIA, Morell AG, et al: Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology 64:99-105, 1973.
47. Gollan JL, Deller DT: Studies on the nature and excretion of biliary copper in man. Clin Sei 44:9-15, 1973.
48. Frydman M, Bonne-Tammir B, Fairer LA, et al: Assignment of the gene for Wilson disease to chromosome 13: Linkage to the esterase D locus. Proc Natl Acad Sei USA 82:1819-1821, 1985.
49. Houwen RH, Scheffer H, Te-Meerman G], et al: Close linkage of the Wilson's disease locus to D13S12 in the chromosomal region 13q21 and not to EDD in 13ql4. Hum Genet 85:560-562, 1990.
50. Bowcock AM, Farrer LA, Hebert JM, et al: Eight closely linked loci place the Wilson disease locus within 13ql4-q21. Am J Hum Genet 43:664-674, 1988.
51. Bull PC, Thomas GR, Rommens JM, et al: The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. JVaf Genet 5:327-337, 1993.
52. Petrukhin K, Fischer SG, Piratsu M, et al: Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. JVaf Genet 5:338-343, 1993.
53. Tanzi RE, Petrukhin K, Chernov I, et al: The Wilson's disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344-350, 1993.
54. Yamaguchi Y, Heiny ME, Gitlin JD: Isolation and characterization of a human liver cDNA as a candidate gene for Wilson's disease. Biochem Biophys Res Commun 197:271-277, 1993.
55. Petrukhin K, Lutsenko S, Chernov I, et al: Characterization of the Wilson's disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 3:1647-1656, 1994.
56. Solioz M, Vulpe C: Cpx-type ATPases: A class of P-type ATPases that pump heavy metals. Trends Biochem Sei 21:237-241, 1996.
57. Sternlieb I: Copper and zinc, in Arias IM, Boyer IL, Fausto N, et al (eds): The Liver: Biology and Pathobiology, vol 3. New York, Raven Press, 1994, pp 585-596.
58. Zhou B, Gitscher J: hCTRl: A human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sei USA 94:74817486, 1997.
59. Klomp LW, Liu SJ, Yuan DS, et al: Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J Biol Chem 272:9221-9226, 1997.
60. Lewis KO: The nature of the copper complexes in bile and their relationship to the absorption and excretion of copper in normal subjects and in Wilson's disease. Gut 14:221-232, 1973.
61. Harada M, Sakisaka S, Yoshitake M, et al: Biliary copper excretion in acutely and chronically copper-loaded rats. Hepatology 17:111-117, 1993,
62. Schilsky ML, Stockert RJ, Sternlieb I: Pleiotropic effect of the LEG mutation: A rodent model of Wilson's disease. Am J Physiol 266:G907G913, 1994.
63. Hung IH, Suzuki M, Yamaguchi Y, et al: Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 272:21461-21466, 1997.
64. Yang XL, Muira N, Kawarada Y, et al: Two forms of Wilson's disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem J 326:897-902, 1997.
65. Pétris MJ, Mercer JFB, Culvenor JG, et al: Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: A novel mechanism of regulated trafficking. EMBO J 15:6084-6095, 1996.
66. Murata Y, Yamakawa E, lizuka T, et al: Failure of copper incorporation into ceruloplasmin in the Golgi apparatus of LEG rat hepatocytes. Biochem Biophys Res Commun 209:349-355, 1995.
67. Terada K, Kawarda Y, Muira N, et al: Copper incorporation into ceruloplasmin in rat livers. Biochim Biophys Acta 1270:58-62, 1995.
68. Ferenci P, Gilliam TC, Gitlin JD, et al: An international symposium on Wilson's and Menkes' disease. Hepatology 24:952-958, 1996.
69. Sokol RJ, Twedt D, McKim JM, et al: Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 107:1788-1798, 1994.
70. Mansouri A, Gaou I, Fromentz B, et al: Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 113:599-605, 1997.
71. Sternlieb I: Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology 55:354-367, 1968.
72. Cox DW: Molecular advances in Wilson disease, in Boyer JL, Ockner RK (eds): Progress in Liver Disease. Philadelphia, WB Saunders, 1996, pp 245-264.
73. Shah AB, Chernov I, Zhang HT, et al: Identification and analysis of mutations in the Wilson disease gene (ATP7B): Population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317-328, 1997.
74. Maier-Dobersberger T, Ferenci P, Polli C, et al: Detection of the His 1069 Glu mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 127:21-26, 1997.
75. Waldenstrom E, Lagerkvist A, Dahlman T, et al: Efficient detection of mutations in Wilson's disease by manifold sequencing. Genomics 37:303-309, 1996.
76. Terada K, Nakako T, Yang XL, et al: Restoration of holoceruloplasmin synthesis in LEG rat after infusion of recombinant adenovirus bearing WND cDNA. JBiol Chem 273:1815-1820, 1998.
77. Yoshida Y, Tokusoshi Y, Lee GH, et al: Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 111:1654-1660, 1996.